Cargando…

Association between cyclin D1 (CCND1) G870A polymorphism and gastric cancer risk: a meta-analysis

Published data on the association between cyclin D1 (CCND1) G870A polymorphism and gastric cancer (GC) risk are inconclusive. Thus, we conducted a meta-analysis to evaluate the relationship between CCND1 G870A polymorphism and GC risk. We searched PubMed, EMBASE, Web of science and the Cochrane Libr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Yafei, Zeng, Xianling, Lu, Hongwei, Ji, Hong, Zhao, Enfa, Li, Yiming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5323219/ https://www.ncbi.nlm.nih.gov/pubmed/27623072 http://dx.doi.org/10.18632/oncotarget.11848

Ejemplares similares

G870A Polymorphic Variants of CCND1 Gene and Cyclin D1 Protein Expression as Prognostic Markers in Laryngeal Lesions
por: Kowalczyk, Magdalena Marianna, et al.
Publicado: (2022)

Influence of CCND1 G870A polymorphism on the risk of HBV-related HCC and cyclin D1 splicing variant expression in Chinese population
por: Zeng, Zhenzhen, et al.
Publicado: (2015)

The association between CCND1 G870A polymorphism and colorectal cancer risk: A meta-analysis
por: Xie, Mei, et al.
Publicado: (2017)

Cyclin D1 G870A Polymorphism and Risk of Nasopharyngeal Carcinoma: A Meta-Analysis
por: Li, Meng, et al.
Publicado: (2013)

Cyclin D1 A870G polymorphism and the risk of colorectal cancer and adenoma
por: Schernhammer, E S, et al.
Publicado: (2006)

The association between CCND1 G870A polymorphism and colorectal cancer risk: A meta-analysis: Erattum
Publicado: (2018)

Single Nucleotide Polymorphism (A870G) of the CCND1 gene: association with colorectal cancer susceptibility
por: Montazer Haghighi, Mahdi, et al.
Publicado: (2017)

The influence of the Cyclin D1 870 G>A polymorphism as an endometrial cancer risk factor
por: Ashton, Katie A, et al.
Publicado: (2008)

Association between cyclin D1 G870A polymorphism and hepatocellular carcinoma risk: a meta-analysis
por: Luo, Tao, et al.
Publicado: (2016)

Cyclin D1 G870A Polymorphism and Risk of Nasopharyngeal Carcinoma: A Case-Control Study and Meta-Analysis
por: Liao, Dan, et al.
Publicado: (2014)

Association between 8q24 (rs13281615 and rs6983267) polymorphism and breast cancer susceptibility: a meta-analysis involving 117,355 subjects
por: Zhang, Yafei, et al.
Publicado: (2016)

Effect of the CCND1 A870G polymorphism on prostate cancer risk: a meta-analysis of 3,820 cases and 3,825 controls
por: Zheng, Min, et al.
Publicado: (2015)

The CCND1 870G>A polymorphism is a risk factor for t(11;14)(q13;q32) multiple myeloma
por: Weinhold, Niels, et al.
Publicado: (2013)

Cyclin D1 G870A Polymorphism: Relation to the Risk of ALL Development, Prognosis Impact, and Methotrexate Cytotoxicity
por: El Menshawy, Nadia, et al.
Publicado: (2020)

The CCND1 c.870G risk allele is enriched in individuals of African ancestry with plasma cell dyscrasias
por: Baughn, Linda B., et al.
Publicado: (2020)

Association between the Cyclin D(1) G870A polymorphism and the susceptibility to and prognosis of upper aerodigestive tract squamous cell carcinomas: an updated meta-analysis
por: Meng, Yichen, et al.
Publicado: (2016)

Association between Cyclin D1 G870A (rs9344) polymorphism and cancer risk in Indian population: meta-analysis and trial sequential analysis
por: Thakur, Nisha, et al.
Publicado: (2018)

Cyclin D1 G870A Polymorphism Contributes to Colorectal Cancer Susceptibility: Evidence from a Systematic Review of 22 Case-Control Studies
por: Yang, Yongzhi, et al.
Publicado: (2012)

Association Between Polymorphism rs678653 in Human Cyclin D1 Gene (CCND1) and Susceptibility to Cancer: A Meta-Analysis
por: Dai, Xichao, et al.
Publicado: (2016)

Association between cyclin D1 G870A polymorphism and cervical cancer risk: a cumulative meta-analysis involving 2,864 patients and 3,898 controls
por: Hu, Yuan-Yuan, et al.
Publicado: (2014)

Lack of association of the cyclin D1 G870A variation with oral carcinoma risk: Evidence from 2,404 subjects
por: ZHUO, XIAN-LU, et al.
Publicado: (2012)

Relevance of cyclin D1b expression and CCND1 polymorphism in the pathogenesis of multiple myeloma and mantle cell lymphoma
por: Krieger, Sophie, et al.
Publicado: (2006)

Oesophageal cancer and amplification of the human cyclin D gene CCND1/PRAD1.
por: Adélaide, J., et al.
Publicado: (1995)

Prognostic and Clinicopathological Significance of CCND1/Cyclin D1 Upregulation in Melanomas: A Systematic Review and Comprehensive Meta-Analysis
por: González-Ruiz, Lucía, et al.
Publicado: (2021)

Oncogenic c-terminal cyclin D1 (CCND1) mutations are enriched in endometrioid endometrial adenocarcinomas
por: Xu, Jia, et al.
Publicado: (2018)

Prognostic Importance of Cell Cycle Regulators Cyclin D1 (CCND1) and Cyclin-Dependent Kinase Inhibitor 1B (CDKN1B/p27) in Sporadic Gastric Cancers
por: Minarikova, Petra, et al.
Publicado: (2016)

Cyclin D1 overexpression in Algerian breast cancer women: correlation with CCND1 amplification and clinicopathological parameters
por: Mohammedi, Latifa, et al.
Publicado: (2019)

Prognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small-cell lung cancer.
por: Betticher, D. C., et al.
Publicado: (1996)

Impact of interaction between the G870A and EFEMP1 gene polymorphism on glioma risk in Chinese Han population
por: Yang, Libin, et al.
Publicado: (2017)

Association between FGFR2 (rs2981582, rs2420946 and rs2981578) polymorphism and breast cancer susceptibility: a meta-analysis
por: Zhang, Yafei, et al.
Publicado: (2016)

Novel RNA-binding activity of MYF5 enhances Ccnd1/Cyclin D1 mRNA translation during myogenesis
por: Panda, Amaresh C., et al.
Publicado: (2016)

Cyclin D1 + large B-cell lymphoma with altered CCND1 and BCL-6 rearrangements: a diagnostic challenge
por: Gao, Da, et al.
Publicado: (2019)

Prognostic and Predictive Value of CCND1/Cyclin D1 Amplification in Breast Cancer With a Focus on Postmenopausal Patients: A Systematic Review and Meta-Analysis
por: Jeffreys, Sarah A., et al.
Publicado: (2022)

MicroRNA-365 Inhibits Cell Growth and Promotes Apoptosis in Melanoma by Targeting BCL2 and Cyclin D1 (CCND1)
por: Zhu, Yong, et al.
Publicado: (2018)

Prognostic Significance of Cyclins A2, B1, D1, and E1 and CCND1 Numerical Aberrations in Oral Squamous Cell Carcinomas
por: Monteiro, Luís Silva, et al.
Publicado: (2018)

AURKB promotes gastric cancer progression via activation of CCND1 expression
por: Nie, Min, et al.
Publicado: (2020)

CCND1 gene polymorphic variants in patients with differentiated thyroid carcinoma
por: HRYHOROWICZ, SZYMON, et al.
Publicado: (2015)

Association between RAD51 135 G/C polymorphism and risk of 3 common gynecological cancers: A meta-analysis
por: Zeng, Xianling, et al.
Publicado: (2018)

Polymorphisms of microRNA target genes IL12B, INSR, CCND1 and IL10 in gastric cancer
por: Petkevicius, Vytenis, et al.
Publicado: (2017)

Association between XRCC1 polymorphisms and the risk of cervical cancer: a meta-analysis based on 4895 subjects
por: Zeng, Xianling, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_9fntlh44pjp8afn4c29vjmo6p2